SHENKMAN CAPITAL MANAGEMENT INC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 24 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
SHENKMAN CAPITAL MANAGEMENT INC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$6,138,941
-1.7%
7,066,000
-1.6%
0.46%
-5.5%
Q2 2023$6,246,794
-36.2%
7,180,000
-36.6%
0.49%
-34.5%
Q1 2023$9,786,521
-34.5%
11,317,000
-32.9%
0.74%
-20.0%
Q4 2022$14,946,863
+18.2%
16,861,000
+20.0%
0.93%
+31.0%
Q3 2022$12,647,000
-0.4%
14,050,000
-5.6%
0.71%
-7.8%
Q2 2022$12,693,000
+121.3%
14,886,000
+131.9%
0.77%
+97.2%
Q4 2021$5,736,0006,419,0000.39%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
BRAIDWELL LP 134,334,000$116,802,1483.85%
STEELHEAD PARTNERS LLC 46,562,000$40,485,6592.64%
DeepCurrents Investment Group LLC 40,000,000$34,578,4961.35%
WOLVERINE ASSET MANAGEMENT LLC 76,557,000$66,300,8520.78%
SHENKMAN CAPITAL MANAGEMENT INC 11,317,000$9,786,5210.74%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,856,000$4,199,9000.62%
Ionic Capital Management LLC 2,000,000$1,726,3490.50%
Empyrean Capital Partners, LP 15,000,000$12,980,0000.44%
Context Capital Management, LLC 4,489$3,9030.33%
Graham Capital Management, L.P. 11,422,000$9,875,7460.30%
View complete list of NOVOCURE LTD shareholders